Novartis Partners with Generate in $1B Biotech Deal
Novartis and Generate forge $1B+ deal to innovate protein therapeutics using generative AI technology.
- Latest
- Trending
Novartis and Generate forge $1B+ deal to innovate protein therapeutics using generative AI technology.
Zydus and Perfect Day join forces to create eco-friendly proteins, revolutionizing sustainable food production worldwide.
Boehringer Ingelheim acquires Saiba Animal Health, boosting pet R&D with innovative therapeutic vaccines.
Ethereum Foundation clarifies funding allocation after $94M ETH transfer sparks sales speculation.
Zydus acquires 50% of Sterling Biotech to enter fermented protein sector, shares fall 6%.
Chinese and US scientists unveil ActFound, an AI model helping optimize drug development by predicting bioactivity efficiently.
Exploring innovative ways to convert plastic waste into food using microbes, offering sustainable solutions to global waste issues.
European biotech set to soar with digital tech aiding sustainable innovations and industrial processes.
AI-designed proteins transform with molecular switches, paving new paths in biotechnology innovation and drug delivery.
Glanbia reports 12.4% EPS growth in H1 2024 amid strong demand and strategic acquisitions.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.